FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamins, and nutritional health in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions.
FDC Limited (FDC) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The FDC share price is ₹392.60 (+0.31% today), with a market capitalisation of ₹64B and a price-to-earnings (P/E) ratio of 20.4. MarketRipple tracks the FDC investment thesis, the ripple-chain impact of market events on FDC Limited, and the Healthcare sector outlook.
Open
₹392.00
High
₹393.90
Low
₹390.00
Prev. Close
₹391.40
52W High
₹442.00
52W Low
₹312.95
Day range
₹390.00–₹393.90
52-week range
₹312.95–₹442.00
Volume
88K
P/E
20.4
ROE
12.3%
D/E
0.01
Margin
13.7%
FDC Limited (NSE: FDC) is currently trading at ₹392.60 (+0.31%).
FDC Limited's market capitalization is ₹64B.
FDC Limited's price-to-earnings (P/E) ratio is 20.4.
FDC Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).